Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Russell C Langan"'
Autor:
Ritesh Kumar, Jongmyung Kim, Matthew P. Deek, Mariam F. Eskander, Prateek Gulhati, Haejin In, Timothy Kennedy, Mihir M. Shah, Miral S. Grandhi, Lyudmyla Berim, Kristen R. Spencer, Russell C. Langan, Howard S. Hochster, Patrick M. Boland, Salma K. Jabbour
Publikováno v:
Current Oncology, Vol 30, Iss 7, Pp 6432-6446 (2023)
Oncological outcomes are improving in gastrointestinal cancer with advancements in systemic therapies, and there is notable potential in combining immunotherapy and radiation therapy (RT) to allow for further improvements. Various preclinical and ear
Externí odkaz:
https://doaj.org/article/729b9f4c7e68413787e8c6f05e59d79e
Autor:
Emma Vail, Ankur P. Choubey, H. Richard Alexander, David A. August, Abril Berry, Patrick M. Boland, Mariam F. Eskander, Miral S. Grandhi, Brittany Haliani, Haejin In, Timothy J. Kennedy, Russell C. Langan, Jason C. Maggi, Henry A. Pitt, Shridar Ganesan, Brett L. Ecker
Publikováno v:
Cancer Medicine, Vol 13, Iss 1, Pp n/a-n/a (2024)
Abstract Background Several cytotoxic chemotherapies have demonstrated efficacy in improving recurrence‐free survival (RFS) following resection of Stage II–IV colorectal cancer (CRC). However, the temporal dynamics of response to such adjuvant th
Externí odkaz:
https://doaj.org/article/c7d6c4918adb470e867663524ca12d6d
Autor:
Joshua D. Greendyk, William E. Allen, H. Richard Alexander, Toni Beninato, Mariam F. Eskander, Miral S. Grandhi, Timothy J. Kennedy, Russell C. Langan, Jason C. Maggi, Subhajyoti De, Colin M. Court, Brett L. Ecker
Publikováno v:
Biomedicines, Vol 11, Iss 11, p 3058 (2023)
Several molecular biomarkers have been identified to guide induction treatment selection for localized pancreatic ductal adenocarcinoma (PDAC). SMAD4 alterations and low GATA6 expression/modified “Moffitt” basal-like phenotype have each been asso
Externí odkaz:
https://doaj.org/article/3a65d68a4ab643f699fba7f3039a0806
Autor:
Stephanie H. Greco, MD, David A. August, MD, Mihir M. Shah, MD, Chunxia Chen, MS, Dirk F. Moore, PhD, Monika Masanam, BA, Amber L. Turner, MPH, Salma K. Jabbour, MD, Parisa Javidian, MD, Miral S. Grandhi, MD, Timothy J. Kennedy, MD, H. Richard Alexander, MD, Darren R. Carpizo, MD, PhD, Russell C. Langan, MD
Publikováno v:
Surgery Open Science, Vol 3, Iss , Pp 22-28 (2021)
Background: Neoadjuvant therapy (NAT) for T1/T2 pancreatic adenocarcinoma (PDAC) prior to pancreaticoduodenectomy remains controversial. We compared positive margin rates in patients with clinical T1&T2 tumors who did and did not receive NAT. Methods
Externí odkaz:
https://doaj.org/article/5bf9b49f411748fd876da8ad503e6596
Autor:
Alek Zywot, MD, MPH, Amber L. Turner, MPH, Joanna Sesti, MD, Russell C. Langan, MD, Andrew Nguyen, MD, Andreas R. de Biasi, MD, Siva Raja, MD, PhD, Usman Ahmad, MD, Subroto Paul, MD, MPH
Publikováno v:
Surgery Open Science, Vol 2, Iss 3, Pp 140-146 (2020)
Background: Heart and lung transplant patients can develop conditions necessitating general surgery procedures. Their postoperative morbidity and mortality remain poorly characterized and limited to case series from select centers. Methods: The Natio
Externí odkaz:
https://doaj.org/article/a0967dea9c0c4593a7a99b22e898f11f
Autor:
Victor P. Gazivoda, Aaron W. Kangas-Dick, Alissa A. Greenbaum, Joshua Roshal, Chunxia Chen, Dirk F. Moore, Russell C. Langan, Timothy J. Kennedy, Christine Minerowicz, H. Richard Alexander
Publikováno v:
Journal of Surgical Research. 277:131-137
Frequency of PD-L1 expression and the role of immunotherapy in malignant peritoneal mesothelioma (MPM) have not been well characterized. The purpose of this study was to determine PD-L1 expression in patients with MPM and perform an exploratory analy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f5759527b3ba3ba344421572a01beed
https://doi.org/10.1016/j.jss.2022.04.005
https://doi.org/10.1016/j.jss.2022.04.005
Autor:
Mutlay Sayan, Nikhil Yegya-Raman, Stephanie H. Greco, Bin Gui, Andrew Zhang, Anupama Chundury, Miral S. Grandhi, Howard S. Hochster, Timothy J. Kennedy, Russell C. Langan, Usha Malhotra, Vinod K. Rustgi, Mihir M. Shah, Kristen R. Spencer, Darren R. Carpizo, John L. Nosher, Salma K. Jabbour
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Hepatocellular carcinoma (HCC) is the second most common cause of cancer death worldwide, with a majority of HCC patients not suitable for curative therapies. Approximately 70% of initially diagnosed patients cannot undergo surgical resection or tran
Externí odkaz:
https://doaj.org/article/69414f7af8d84fdd8c7ca029ca8aca54
Autor:
Michael Sosin, Surupa Sen Gupta, Jessica S. Wang, Corinne D. Costellic, Aiste Gulla, Alex J. Bartholomew, Suzanne C. O'Neill, Elizabeth M. Hechenbleikner, Brian T. Collins, Sonali Rudra, Sean P. Collins, Krysta M. Chaldekas, Sulakshana Seevaratnam, Russell C. Langan, Shawna C. Willey, Eleni A. Tousimis
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Introduction: Intraoperative radiation therapy (IORT) is a minimally invasive radiation option for select patients with early stage breast cancer. This prospective, single institution, pilot study summarizes patient-reported quality of life (QoL) out
Externí odkaz:
https://doaj.org/article/eab934acda514f47bb426ef7beefc5e6
Autor:
Steven A. Rosenberg, Carolyn M. Laurencot, Donald E. White, Kathleen E. Morton, Daniel A. Zlott, Russell C. Langan, Jenny J. Hong, Peter A. Prieto, John R. Wunderlich, Nicholas P. Restifo, Deborah E. Citrin, Marybeth S. Hughes, Udai S. Kammula, Giao Q. Phan, James C. Yang, Richard M. Sherry, Marcos R. Garcia, Michelle M. Langhan, Colin A. Gross, Mark E. Dudley
Supplementary Figure S1; Supplementary Table S1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29f94fb798be3e5d1e9f601a5d4dba52
https://doi.org/10.1158/1078-0432.22442954
https://doi.org/10.1158/1078-0432.22442954
Autor:
Steven A. Rosenberg, Carolyn M. Laurencot, Donald E. White, Kathleen E. Morton, Daniel A. Zlott, Russell C. Langan, Jenny J. Hong, Peter A. Prieto, John R. Wunderlich, Nicholas P. Restifo, Deborah E. Citrin, Marybeth S. Hughes, Udai S. Kammula, Giao Q. Phan, James C. Yang, Richard M. Sherry, Marcos R. Garcia, Michelle M. Langhan, Colin A. Gross, Mark E. Dudley
Purpose: Tumor‐infiltrating lymphocytes (TIL) and interleukin (IL)-2 administered following lymphodepletion can cause the durable complete regression of bulky metastatic melanoma in patients refractory to approved treatments. However, the generatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::009bd66d72b8f448ebf39ad2c901b465
https://doi.org/10.1158/1078-0432.c.6519572.v1
https://doi.org/10.1158/1078-0432.c.6519572.v1